<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36496030</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8227</ISSN><JournalIssue CitedMedium="Internet"><Volume>195</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Diabetes research and clinical practice</Title><ISOAbbreviation>Diabetes Res Clin Pract</ISOAbbreviation></Journal><ArticleTitle>The bidirectional association between diabetes and long-COVID-19 - A systematic review.</ArticleTitle><Pagination><StartPage>110202</StartPage><MedlinePgn>110202</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diabres.2022.110202</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-8227(22)01016-6</ELocationID><Abstract><AbstractText>Some evidence suggests that diabetes may be a risk factor for the development of post-acute sequelae of COVID-19 (PASC). Recent data also indicate that new-onset diabetes may be a complication of COVID-19. Here, we review the existing evidence. Following PRISMA guidelines, we conducted a systematic review through August 8, 2022. We included longitudinal studies reporting on the risk of PASC (i.e., sequelae that extend beyond four weeks after initial infection) in people with and without diabetes, and studies reporting on the risk of new-onset diabetes in people with vs without COVID-19 with a minimum of 4-weeks of follow-up. All studies were published in English. Among 5,532 studies screened, 39 were included in the final review. Among 25 studies reporting on diabetes and PASC, 44&#xa0;% (n&#xa0;=&#xa0;11) identified diabetes as a significant risk factor for PASC (increased relative risk ranging from 7&#xa0;% to 342&#xa0;%) while 56&#xa0;% (n&#xa0;=&#xa0;14) did not. Among 14 studies reporting on new-onset diabetes, 12 (86&#xa0;%) reported that COVID-19 (vs no COVID) was significantly associated with new-onset diabetes with increased risks ranging from 11&#xa0;% to 276&#xa0;%. COVID-19 survivors may be at increased risk for new-onset diabetes, but whether pre-existing diabetes is also a risk factor for PASC remains unclear.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: Jessica.harding@emory.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Sofia A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Mohammed K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States; Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofotokun</LastName><ForeName>Igho</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States; Department of Behavioral Science and Education, Rollins School of Public Health, Emory University, Atlanta, GA, United States; Grady Healthcare System Infection Disease Program, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gander</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Center for Research and Evaluation, Kaiser Permanente Georgia, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Shivani A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magliano</LastName><ForeName>Dianna J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patzer</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Diabetes Res Clin Pract</MedlineTA><NlmUniqueID>8508335</NlmUniqueID><ISSNLinking>0168-8227</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Infectious disease</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>10</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36496030</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pii">S0168-8227(22)01016-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Research. NIHR themed review: living with Covid19 - second review 2021. Available from: https://evidence.nihr.ac.uk/wp-content/uploads/2021/03/NIHR_COVID_REPORT_FINAL-150321-1_1_.pdf [accessed 10 August 2022].</Citation></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251&#x2013;3222. doi: 10.1001/jama.2020.22717. [published Online First: 2020/11/19]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374 doi: 10.1136/bmj.n1648. [published Online First: 2021/07/28]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31 doi: 10.1016/j.eclinm.2020.100683. [published Online First: 2021/01/26]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Martinez M.M., Carrera Boada C., Madera-Silva M.D., et al. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151&#x2013;217. doi: 10.1016/j.arteri.2020.10.001. [published Online First: 2020/12/12]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M., Campopiano M.C., Mantuano M., et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782&#x2013;792. doi: 10.1016/S2213-8587(20)30238-2. [published Online First: 2020/07/21]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncon L., Zuin M., Rigatelli G., et al. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020;127 doi: 10.1016/j.jcv.2020.104354. [published Online First: 2020/04/20]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104354</ArticleId><ArticleId IdType="pmc">PMC7195018</ArticleId><ArticleId IdType="pubmed">32305882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman BL, Yu J, Tanaka C, et al. Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic. JAMA Pediatrics 2022;176(4). doi: 10.1001/jamapediatrics.2021.5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787677</ArticleId><ArticleId IdType="pubmed">35072727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamrath C., Rosenbauer J., Eckert A.J., et al. Incidence of type 1 diabetes in children and adolescents during the COVID-19 pandemic in Germany: results from the DPV registry. Diabetes Care. 2022;45(8):1762&#x2013;1771. doi: 10.2337/dc21-0969. [published Online First: 2022/01/20]</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-0969</ArticleId><ArticleId IdType="pubmed">35043145</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman R., Cohen E., Stukel T.A., et al. Examination of trends in diabetes incidence among children during the COVID-19 pandemic in Ontario, Canada, from March 2020 to September 2021. JAMA Netw Open. 2022;5(7):e2223394. doi: 10.1001/jamanetworkopen.2022.23394. [published Online First: 2022/07/26]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23394</ArticleId><ArticleId IdType="pmc">PMC9315418</ArticleId><ArticleId IdType="pubmed">35877126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., et al. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870&#x2013;884. doi: 10.1111/dom.14269. [published Online First: 2020/11/28]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. doi: 10.1016/s2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372 doi: 10.1136/bmj.n71. [published Online First: 2021/03/31]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris J.M., Simpson B.S., Ball R., et al. A modified Newcastle-Ottawa scale for assessment of study quality in genetic urological research. Eur Urol. 2021;79(3):325&#x2013;336. doi: 10.1016/j.eururo.2020.12.017. [published Online First: 2020/12/31]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.12.017</ArticleId><ArticleId IdType="pubmed">33375994</ArticleId></ArticleIdList></Reference><Reference><Citation>Magliano D.J., Islam R.M., Barr E.L.M., et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019;366 doi: 10.1136/bmj.l5003. [published Online First: 2019/09/13]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l5003</ArticleId><ArticleId IdType="pmc">PMC6737490</ArticleId><ArticleId IdType="pubmed">31511236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkwood B., Sterne J. 2nd edition. Wiley-Blackwell; 2001. Essentials of medical statistics.</Citation></Reference><Reference><Citation>Profili F., Seghieri G., Francesconi P. Effect of diabetes on short-term mortality and incidence of first hospitalizations for cardiovascular events after recovery from SARS-CoV-2 infection. Diabetes Res Clin Pract. 2022;187 doi: 10.1016/j.diabres.2022.109872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.109872</ArticleId><ArticleId IdType="pmc">PMC9006403</ArticleId><ArticleId IdType="pubmed">35429573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai C., Chen K., Li S., et al. Effect of elevated fasting blood glucose level on the 1-year mortality and sequelae in hospitalized COVID-19 patients: a bidirectional cohort study. J Med Virol. 2022;94(7):3240&#x2013;3250. doi: 10.1002/jmv.27737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27737</ArticleId><ArticleId IdType="pmc">PMC9088618</ArticleId><ArticleId IdType="pubmed">35357022</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen SH, Jensen B-EO, Tanislav C, et al. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection 2022. doi: 10.1007/s15010-022-01784-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="pubmed">35355237</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter F., Mannan A., Mehedi H.M.H., et al. Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes Metab Syndr. 2020;14(6):2031&#x2013;2208. doi: 10.1016/j.dsx.2020.10.016. [published Online First: 2020/10/29]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7575434</ArticleId><ArticleId IdType="pubmed">33113469</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesan GSCQ, Keerthana D, Yamini R, et al. 3-Month symptom-based ambidirectional follow-up study among recovered COVID-19 patients from a Tertiary Care Hospital using telehealth in Chennai, India. INQUIRY: J Health Care Organiz Provision Financ 2021;58:004695802110601. doi: 10.1177/00469580211060165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721686</ArticleId><ArticleId IdType="pubmed">34915771</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic-Jukic N., Juric I., Furic-Cunko V., et al. Follow-up of renal transplant recipients after acute COVID-19&#x2014;a prospective cohort single-center study. Immun Inflammation Dis. 2021;9(4):1563&#x2013;1572. doi: 10.1002/iid3.509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.509</ArticleId><ArticleId IdType="pmc">PMC8426882</ArticleId><ArticleId IdType="pubmed">34414665</ArticleId></ArticleIdList></Reference><Reference><Citation>Crankson S, Pokhrel S, Anokye NK. Determinants of COVID-19-related length of hospital stays and long COVID in Ghana: a cross-sectional analysis. Int J Environ Res Public Health 2022;19(1). doi: 10.3390/ijerph19010527 [published Online First: 2022/01/12].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744866</ArticleId><ArticleId IdType="pubmed">35010786</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185(5):881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhiraja S, Indrayan A, Mahajan M. Effect of COVID-19 vaccine on long-COVID: A 2-year follow-up observational study from hospitals in north India. medRxiv 2022:2022.07.18.22277740. doi: 10.1101/2022.07.18.22277740.</Citation></Reference><Reference><Citation>Rinaldi R, Basile M, Salzillo C, et al. Myocardial injury portends a higher risk of mortality and long-term cardiovascular sequelae after hospital discharge in COVID-19 survivors. J Clin Med 2022;11(19). doi: 10.3390/jcm11195964 [published Online First: 20221010].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9573406</ArticleId><ArticleId IdType="pubmed">36233830</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. The Lancet Digital Health. 2022;4(7):e532&#x2013;e541. doi: 10.1016/s2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S.M., Liu T.C., Motwani Y., et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37(8):1988&#x2013;1995. doi: 10.1007/s11606-022-07523-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou G.N., Baraff A., Fox A., et al. Rates and factors associated with documentation of diagnostic codes for long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open. 2022;5(7):e2224359. doi: 10.1001/jamanetworkopen.2022.24359. [published Online First: 20220701]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.24359</ArticleId><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeigue P.M., McGurnaghan S., Blackbourn L., et al. Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Diabetes Care. 2022 doi: 10.2337/dc22-0385. [published Online First: 2022/07/27]</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-0385</ArticleId><ArticleId IdType="pubmed">35880797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayar M., Varghese C., Kanwar A., et al. SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study. Gut. 2022;71(7):1444&#x2013;2147. doi: 10.1136/gutjnl-2021-326218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326218</ArticleId><ArticleId IdType="pubmed">34764192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wander P.L., Lowy E., Beste L.A., et al. The incidence of diabetes among 2,777,768 veterans with and without recent SARS-CoV-2 infection. Diabetes Care. 2022;45(4):782&#x2013;878. doi: 10.2337/dc21-1686.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1686</ArticleId><ArticleId IdType="pmc">PMC9016731</ArticleId><ArticleId IdType="pubmed">35085391</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9. [published Online First: 2021/04/23]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu A.C., Carton T.W., Saydah S., et al. Prevalence of Select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2. JAMA Netw Open. 2022;5(2):e2147053. doi: 10.1001/jamanetworkopen.2021.47053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.47053</ArticleId><ArticleId IdType="pmc">PMC8817203</ArticleId><ArticleId IdType="pubmed">35119459</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021 doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E, Douiri A, Sun X, et al. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med 2022;19(7):e1004052. doi: 10.1371/journal.pmed.1004052 [published Online First: 2022/07/20].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HG, Dagliati A, Shakeri Hossein Abad Z, et al. International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med 2022;5(1):81. doi: 10.1038/s41746-022-00623-8 [published Online First: 2022/06/30].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242995</ArticleId><ArticleId IdType="pubmed">35768548</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett CE, Koyama AK, Alvarez P, et al. Risk for newly diagnosed diabetes &amp;gt;30 days after SARS-CoV-2 infection among persons aged &amp;lt;18 years &#x2014; United States, March 1, 2020&#x2013;June 28, 2021. MMWR Morbidity and Mortality Weekly Rep 2022;71(2):59&#x2013;65. doi: 10.15585/mmwr.mm7102e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall E.K., Olaker V.R., Kaelber D.C., et al. Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Netw Open. 2022;5(9):e2233014. doi: 10.1001/jamanetworkopen.2022.33014. [published Online First: 20220901]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33014</ArticleId><ArticleId IdType="pmc">PMC9508649</ArticleId><ArticleId IdType="pubmed">36149658</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M., Pal R., Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(4):591&#x2013;653. doi: 10.1016/j.pcd.2022.05.009. [published Online First: 2022/06/03]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO coronavirus (COVID-19) dashboard 2022. Available from: https://covid19who.int/ accessed 20 July 2022.</Citation></Reference><Reference><Citation>Smith S.M., Boppana A., Traupman J.A., et al. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J Med Virol. 2021;93(1):409&#x2013;415. doi: 10.1002/jmv.26227. [published Online First: 2020/06/27]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26227</ArticleId><ArticleId IdType="pmc">PMC7361926</ArticleId><ArticleId IdType="pubmed">32589756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellido V, Perez A. COVID-19 and diabetes. J Clin Med 2021;10(22). doi: 10.3390/jcm10225341 [published Online First: 2021/11/28].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618368</ArticleId><ArticleId IdType="pubmed">34830623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipscombe L.L., Hwee J., Webster L., et al. Identifying diabetes cases from administrative data: a population-based validation study. BMC Health Serv Res. 2018;18(1):316. doi: 10.1186/s12913-018-3148-0. [published Online First: 2018/05/04]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-018-3148-0</ArticleId><ArticleId IdType="pmc">PMC5932874</ArticleId><ArticleId IdType="pubmed">29720153</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkwai HM, Khalifa AM, Ahmed AM, et al. Persistence of COVID-19 symptoms beyond 3 months and the delayed return to the usual state of health in Saudi Arabia: a cross-sectional study. SAGE Open Med 2022;10:20503121221129918. doi: 10.1177/20503121221129918 [published Online First: 20221008].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548451</ArticleId><ArticleId IdType="pubmed">36226231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142. [published Online First: 2021/01/28]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3. [published Online First: 2021/06/25]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1. [published Online First: 2022/01/27]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Guijarro C., Torres-Macho J., et al. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;70(12):2917&#x2013;2921. doi: 10.2337/db21-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0329</ArticleId><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R., Davis A., Stanley B., et al. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res. 2021;12:93&#x2013;104. doi: 10.2147/POR.S316186. [published Online First: 2021/08/20]</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/POR.S316186</ArticleId><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechi A., Al-Khalidi A., Al-Darraji R., et al. Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus. Int J Diabetes Dev Ctries. 2022;42(1):49&#x2013;52. doi: 10.1007/s13410-021-00994-w. [published Online First: 20210824]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13410-021-00994-w</ArticleId><ArticleId IdType="pmc">PMC8382933</ArticleId><ArticleId IdType="pubmed">34456528</ArticleId></ArticleIdList></Reference><Reference><Citation>Messin L, Puyraveau M, Benabdallah Y, et al. COVEVOL: natural evolution at 6 months of COVID-19. Viruses 2021;13(11). doi: 10.3390/v13112151 [published Online First: 20211025].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="pubmed">34834958</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NN, Hoang VT, Dao TL, et al. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Front Med 2022;9. doi: 10.3389/fmed.2022.794550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8915119</ArticleId><ArticleId IdType="pubmed">35280874</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033. [published Online First: 20210607]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y. [published Online First: 2021/03/12]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaksi N, Teker AG, Imre A. Long COVID in hospitalized COVID-19 Patients: a retrospective cohort study. Iran J Public Health 2022. doi: 10.18502/ijph.v51i1.8297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8837882</ArticleId><ArticleId IdType="pubmed">35223629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372 doi: 10.1136/bmj.n693. [published Online First: 2021/04/02]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Horberg M.A., Watson E., Bhatia M., et al. Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat Commun. 2022;13(1):5822. doi: 10.1038/s41467-022-33573-6. [published Online First: 20221012]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33573-6</ArticleId><ArticleId IdType="pmc">PMC9556630</ArticleId><ArticleId IdType="pubmed">36224218</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571. doi: 10.1038/s41467-021-26513-3. [published Online First: 20211112]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>